IRIS - Res&Arch Institutional Research Information System - Research & Archive

PASQUALUCCI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.549
EU - Europa 1.960
AS - Asia 1.044
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.539
IE - Irlanda 482
UA - Ucraina 450
SG - Singapore 340
IT - Italia 338
SE - Svezia 257
HK - Hong Kong 221
VN - Vietnam 203
FI - Finlandia 106
CN - Cina 101
KR - Corea 101
DE - Germania 98
RU - Federazione Russa 87
TR - Turchia 59
GB - Regno Unito 39
BE - Belgio 20
CH - Svizzera 18
FR - Francia 18
PL - Polonia 13
AT - Austria 10
LB - Libano 8
NL - Olanda 8
GR - Grecia 7
UZ - Uzbekistan 5
BR - Brasile 4
CA - Canada 4
ES - Italia 4
MX - Messico 3
PA - Panama 3
TH - Thailandia 3
AR - Argentina 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EU - Europa 2
IN - India 2
ID - Indonesia 1
LU - Lussemburgo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.563
Salva come PNG Salva come JPEG
Città #
Dublin 482
Chandler 443
Singapore 270
Jacksonville 251
San Mateo 251
Hong Kong 221
Boardman 203
Dong Ket 202
Altamura 135
Santa Clara 133
Perugia 123
Medford 116
Princeton 113
Seoul 101
Ann Arbor 97
Lawrence 90
Wilmington 85
Andover 66
Izmir 55
Des Moines 42
Beijing 40
Saint Petersburg 38
Ashburn 27
Norwalk 26
Brussels 20
Falls Church 19
Woodbridge 17
Amelia 16
Helsinki 14
New York 14
West Jordan 14
Los Angeles 13
San Paolo di Civitate 12
Dearborn 10
Dallas 9
Redwood City 8
Chicago 7
Nanning 7
Shanghai 7
Den Haag 6
Moscow 6
Redmond 6
Frankfurt Am Main 5
Jamaica 5
Philadelphia 5
Auburn Hills 4
Houston 4
San Diego 4
Vienna 4
Athens 3
Barcelona 3
Istanbul 3
Khon Kaen 3
Modena 3
Panama City 3
Simi Valley 3
Cambridge 2
Carbonia 2
Corona 2
Fairfield 2
Foligno 2
Guangzhou 2
Lausanne 2
Mar del Plata 2
Nanjing 2
Ottawa 2
Shaoxing 2
Warsaw 2
Boydton 1
Bratislava 1
Buffalo 1
Edinburgh 1
Florence 1
Frankfurt am Main 1
Galliate 1
Genoa 1
Hangzhou 1
Hanoi 1
Hanover 1
Hebi 1
Hereford 1
Kocaeli 1
Lanzhou 1
London 1
Luton 1
Luxembourg 1
Madrid 1
Mainz 1
Massa 1
Milan 1
Monte Santo 1
Mountain View 1
Munich 1
Palermo 1
Pikermi 1
Prata Di Pordenone 1
Richmond 1
Rome 1
San Giuliano Milanese 1
Serio 1
Totale 3.923
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 113
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. 107
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 96
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. 94
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence 90
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 89
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 85
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 82
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 82
Analysis of the coding genome of diffuse large B cell lymphoma 80
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. 79
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 77
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. 75
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 75
Alterations of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 74
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. 73
AID is required for germinal center-derived lymphomagenesis. 70
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 70
BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. 70
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 69
B-cell receptor signaling derailed in lymphomas. 67
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. 67
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. 67
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 66
BRAF mutations in hairy-cell leukemia. 65
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 64
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. 63
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. 61
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 61
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. 60
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 60
Proto-oncogenes and Tumor Suppressor Genes in Hematopoietic Malignancies 59
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 59
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 58
Expression of the AID protein in normal and neoplastic B cells. 58
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3ß inhibition 57
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 56
Molecular pathogenesis of germinal center-derived B cell lymphomas 56
Hypermutation of multiple proto-oncogenes in B-cell Diffuse Large Cell Lymphomas 55
Targeted antibodies in the treatment of lymphomas. 55
IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE ANTI-PROMYELOCYTIC LEUKEMIA (ANTI-PML) MONOCLONAL ANTIBODY PG-M3 54
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. 54
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 54
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. 54
Pathology and Molecular Pathogenesis of DLBCL and Related Entities 53
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? 52
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma 52
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). 51
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. 49
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 47
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. 47
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization 47
Molecular Biology of Lymphoma 46
The genetics of nodal marginal zone lymphoma 46
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. 45
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 45
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 44
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression 44
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma 44
Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma 44
Towards patient-based cancer therapeutics. 43
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. 42
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 41
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. 41
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 41
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 41
Genetics of follicular lymphoma transformation. 41
Repurposing Dasatinib for diffuse large B cell lymphoma. 41
Molecular Biology of Lymphoma 41
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 40
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. 40
Molecular Genetics of Lymphoma 40
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. 39
Molecular pathogenesis of B cell malignancy: the role of BCL-6. 39
Immunotoxin therapy of hematological malignancies. 39
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. 39
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells 38
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. 38
Molecular pathogenesis of diffuse large B-cell lymphoma 38
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis 38
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome 36
New approaches to lymphoma diagnosis. 36
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 36
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. 36
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. 36
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program 35
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. 35
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. 35
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 34
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis 34
Genetics of diffuse large b-cell lymphoma 34
Emerging epigenetic-modulating therapies in lymphoma 34
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 33
Dissecting KMT2D missense mutations in Kabuki syndrome patients 33
Fractal-like distributions over the rational numbers in high-throughput biological and clinical data. 32
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 30
Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL 29
The germinal center in the pathogenesis of B cell lymphomas 29
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. 28
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. 28
Totale 5.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 0 67 5 66 5 86 20 27 18
2020/20211.038 9 75 36 74 287 44 68 6 113 28 76 222
2021/2022961 24 180 14 61 43 11 14 291 16 35 124 148
2022/20231.607 125 313 23 144 98 170 1 72 604 5 41 11
2023/2024671 33 51 31 11 4 5 174 9 96 31 79 147
2024/2025627 102 175 20 49 281 0 0 0 0 0 0 0
Totale 5.792